MK-2206
Description
"An orally potent and highly selective non-ATP-competitive allosteric Akt inhibitor that has nanomolar IC50 values and broad preclinical anti-tumor activities. Source: [1]
Alternative names
- MK 2206
- MK2206
Usage Notes
References